Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Nov 30, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 10.91%36.27B | 20.53%8.52B | 13.12%32.7B | 11.91%8.27B | 2.85%7.07B | -10.33%28.91B | -9.69%7.15B | -8.33%7.49B | -7.81%7.39B | -15.45%6.87B |
| Cost of revenue | 7.33%24.7B | 10.67%5.85B | 9.85%23.01B | 5.75%5.74B | 9.99%5.28B | -4.56%20.95B | 0.63%5.43B | -9.89%5.29B | 2.37%5.43B | -10.75%4.8B |
| Gross profit | 19.40%11.57B | 49.77%2.67B | 21.72%9.69B | 28.92%2.53B | -13.76%1.78B | -22.64%7.96B | -31.69%1.73B | -4.33%2.2B | -27.68%1.97B | -24.65%2.07B |
| Operating expense | 5.94%5.38B | 8.49%1.3B | 15.91%5.08B | 21.62%1.25B | 13.22%1.2B | 0.64%4.38B | 7.25%1.21B | -0.61%1.08B | -2.92%1.03B | -1.50%1.06B |
| Operating profit | 34.25%6.19B | 135.25%1.37B | 28.84%4.61B | 36.98%1.28B | -42.26%580.62M | -39.72%3.58B | -62.90%520.69M | -7.68%1.12B | -43.58%933.82M | -39.64%1.01B |
| Net non-operating interest income (expenses) | 87.75%-496K | 121.31%365K | 28.27%-4.05M | -66.20%-1.66M | -72.51%-1.71M | -21.30%-5.64M | -108.00%-2.11M | -72.93%-1.55M | 14.86%-997K | 36.91%-993K |
| Non-operating interest income | 28.40%6.78M | 361.06%2.77M | 211.75%5.28M | 74.32%638K | 23.92%601K | 34.05%1.69M | 20.30%403K | 6.55%439K | 58.44%366K | 70.18%485K |
| Non-operating interest expense | -22.01%7.27M | 3.98%2.41M | 27.13%9.33M | 68.38%2.3M | 56.56%2.31M | 24.02%7.34M | 86.20%2.51M | 51.99%1.99M | -2.78%1.36M | -20.49%1.48M |
| Net investment income | 54.34%199.82M | -116.22%-8.35M | -35.27%129.47M | 119.98%82.01M | 65.17%51.5M | -35.26%200M | 433.76%49.98M | -45.66%81.57M | -62.85%37.28M | -36.57%31.18M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -96.74%26.51M | -100.19%-506K | 39.21%813.02M | 118.46%541.46M | 13,994.20%273.16M | 1,541.06%584.02M | 140.90%86.17M | 252,073.00%251.97M | 247.85M | -1.97M |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 201,548.26%3.24B | 95,182.35%96.98M | -102.52%-1.61M | -101.92%-946K | 84.91%-102K | -85.58%63.85M | -101.86%-7.61M | 381,666.67%22.91M | 337.65%49.23M | -103.04%-676K |
| Less:Other special charges | -201,548.26%-3.24B | -95,182.35%-96.98M | 102.52%1.61M | 101.92%946K | -84.91%102K | 85.58%-63.85M | 101.86%7.61M | -381,666.67%-22.91M | -337.65%-49.23M | 103.04%676K |
| Other non-operating income (expenses) | 220.70%70.38M | 150.24%26.28M | -39.40%21.95M | -172.73%-11.1M | 60.13%10.5M | -60.68%36.21M | -66.21%10.84M | -89.99%3.55M | -43.65%15.27M | 362.05%6.56M |
| Income before tax | 74.63%9.72B | 62.00%1.48B | 24.96%5.57B | 47.29%1.89B | -12.08%913.96M | -34.56%4.46B | -65.17%657.95M | 5.81%1.48B | -28.46%1.28B | -40.02%1.04B |
| Income tax | 86.12%2.7B | 36.20%398.89M | 32.43%1.45B | 20.10%456.63M | 1.64%292.87M | -44.83%1.09B | -90.65%51.98M | -5.38%374.32M | -28.60%380.21M | -42.39%288.15M |
| Net income | 70.58%7.02B | 74.17%1.08B | 22.52%4.12B | 58.75%1.43B | -17.35%621.09M | -30.35%3.36B | -54.54%605.97M | 10.24%1.1B | -28.40%902.24M | -39.05%751.43M |
| Net income continuous operations | 70.58%7.02B | 74.17%1.08B | 22.52%4.12B | 58.75%1.43B | -17.35%621.09M | -30.35%3.36B | -54.54%605.97M | 10.24%1.1B | -28.40%902.24M | -39.05%751.43M |
| Noncontrolling interests | 86.82%136.9M | 161.99%46.31M | -18.54%73.28M | -31.12%15.62M | -28.12%17.68M | -9.34%89.96M | -28.88%17.56M | -17.45%25.12M | -1.05%22.68M | 16.11%24.59M |
| Net income attributable to the company | 70.29%6.89B | 71.60%1.04B | 23.65%4.04B | 61.07%1.42B | -16.98%603.41M | -30.79%3.27B | -55.03%588.41M | 11.11%1.08B | -28.90%879.56M | -40.02%726.84M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 70.29%6.89B | 71.60%1.04B | 23.65%4.04B | 61.07%1.42B | -16.98%603.41M | -30.79%3.27B | -55.03%588.41M | 11.11%1.08B | -28.90%879.56M | -40.02%726.84M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 76.04%336.68 | 75.48%49.96 | 25.05%191.25 | 63.18%66.97 | -15.54%28.47 | -29.48%152.94 | -54.20%27.72 | 12.81%50.47 | -27.53%41.04 | -38.68%33.71 |
| Diluted earnings per share | 76.04%336.68 | 75.48%49.96 | 25.05%191.25 | 63.18%66.97 | -15.54%28.47 | -29.48%152.94 | -54.29%27.6671 | 12.81%50.47 | -27.53%41.04 | -38.68%33.71 |
| Dividend per share | 13.64%75 | 0 | 17.86%66 | 14.29%32 | 0 | 3.70%56 | 3.70%28 | 0 | 3.70%28 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |